Ipsen Aims To Raise €400 Million In IPO

November 23, 2005 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Ipsen, the French pharmaceuticals company, yesterday unveiled plans to raise about €400m ($470m) in an initial public offering, which would reduce the stake of the family of founder Henri Beaufour and raise funds for research.

Twitter
LinkedIn
Facebook
Email
Print

IPO Europe

Ipsen Biopharmaceuticals, Inc.